Cargando…

Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni

BACKGROUND: In January 2021, the World Health Organization published the 2021–2030 roadmap for the control of neglected tropical diseases (NTDs). The goal for schistosomiasis is to achieve elimination as a public health problem (EPHP) and elimination of transmission (EOT) in 78 and 25 countries (by...

Descripción completa

Detalles Bibliográficos
Autores principales: Kura, Klodeta, Ayabina, Diepreye, Hollingsworth, T. Deirdre, Anderson, Roy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842958/
https://www.ncbi.nlm.nih.gov/pubmed/35164842
http://dx.doi.org/10.1186/s13071-022-05178-x
_version_ 1784651155446431744
author Kura, Klodeta
Ayabina, Diepreye
Hollingsworth, T. Deirdre
Anderson, Roy M.
author_facet Kura, Klodeta
Ayabina, Diepreye
Hollingsworth, T. Deirdre
Anderson, Roy M.
author_sort Kura, Klodeta
collection PubMed
description BACKGROUND: In January 2021, the World Health Organization published the 2021–2030 roadmap for the control of neglected tropical diseases (NTDs). The goal for schistosomiasis is to achieve elimination as a public health problem (EPHP) and elimination of transmission (EOT) in 78 and 25 countries (by 2030), respectively. Mass drug administration (MDA) of praziquantel continues to be the main strategy for control and elimination. However, as there is limited availability of praziquantel, it is important to determine what volume of treatments are required, who should be targeted and how frequently treatment must be administered to eliminate either transmission or morbidity caused by infection in different endemic settings with varied transmission intensities. METHODS AND RESULTS: In this paper, we employ two individual-based stochastic models of schistosomiasis transmission developed independently by the Imperial College London (ICL) and University of Oxford (SCHISTOX) to determine the optimal treatment strategies to achieve EOT. We find that treating school-age children (SAC) only is not sufficient to achieve EOT within a feasible time frame, regardless of the transmission setting and observed age–intensity of infection profile. Both models show that community-wide treatment is necessary to interrupt transmission in all endemic settings with low, medium and high pristine transmission intensities. CONCLUSIONS: The required MDA coverage level to achieve either transmission or morbidity elimination depends on the prevalence prior to the start of treatment and the burden of infection in adults. The higher the worm burden in adults, the higher the coverage levels required for this age category through community-wide treatment programmes. Therefore, it is important that intensity and prevalence data are collected in each age category, particularly from SAC and adults, so that the correct coverage level can be calculated and administered. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-8842958
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88429582022-02-16 Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni Kura, Klodeta Ayabina, Diepreye Hollingsworth, T. Deirdre Anderson, Roy M. Parasit Vectors Research BACKGROUND: In January 2021, the World Health Organization published the 2021–2030 roadmap for the control of neglected tropical diseases (NTDs). The goal for schistosomiasis is to achieve elimination as a public health problem (EPHP) and elimination of transmission (EOT) in 78 and 25 countries (by 2030), respectively. Mass drug administration (MDA) of praziquantel continues to be the main strategy for control and elimination. However, as there is limited availability of praziquantel, it is important to determine what volume of treatments are required, who should be targeted and how frequently treatment must be administered to eliminate either transmission or morbidity caused by infection in different endemic settings with varied transmission intensities. METHODS AND RESULTS: In this paper, we employ two individual-based stochastic models of schistosomiasis transmission developed independently by the Imperial College London (ICL) and University of Oxford (SCHISTOX) to determine the optimal treatment strategies to achieve EOT. We find that treating school-age children (SAC) only is not sufficient to achieve EOT within a feasible time frame, regardless of the transmission setting and observed age–intensity of infection profile. Both models show that community-wide treatment is necessary to interrupt transmission in all endemic settings with low, medium and high pristine transmission intensities. CONCLUSIONS: The required MDA coverage level to achieve either transmission or morbidity elimination depends on the prevalence prior to the start of treatment and the burden of infection in adults. The higher the worm burden in adults, the higher the coverage levels required for this age category through community-wide treatment programmes. Therefore, it is important that intensity and prevalence data are collected in each age category, particularly from SAC and adults, so that the correct coverage level can be calculated and administered. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2022-02-14 /pmc/articles/PMC8842958/ /pubmed/35164842 http://dx.doi.org/10.1186/s13071-022-05178-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Kura, Klodeta
Ayabina, Diepreye
Hollingsworth, T. Deirdre
Anderson, Roy M.
Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
title Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
title_full Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
title_fullStr Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
title_full_unstemmed Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
title_short Determining the optimal strategies to achieve elimination of transmission for Schistosoma mansoni
title_sort determining the optimal strategies to achieve elimination of transmission for schistosoma mansoni
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842958/
https://www.ncbi.nlm.nih.gov/pubmed/35164842
http://dx.doi.org/10.1186/s13071-022-05178-x
work_keys_str_mv AT kuraklodeta determiningtheoptimalstrategiestoachieveeliminationoftransmissionforschistosomamansoni
AT ayabinadiepreye determiningtheoptimalstrategiestoachieveeliminationoftransmissionforschistosomamansoni
AT hollingsworthtdeirdre determiningtheoptimalstrategiestoachieveeliminationoftransmissionforschistosomamansoni
AT andersonroym determiningtheoptimalstrategiestoachieveeliminationoftransmissionforschistosomamansoni